Andrea V. Lopez

798 total citations
10 papers, 586 citations indexed

About

Andrea V. Lopez is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Andrea V. Lopez has authored 10 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 3 papers in Hematology. Recurrent topics in Andrea V. Lopez's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Andrea V. Lopez is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Andrea V. Lopez collaborates with scholars based in United States, Spain and Puerto Rico. Andrea V. Lopez's co-authors include Renier J. Brentjens, Terence J. Purdon, Anthony F. Daniyan, Nicholas F. Kuhn, Kevin J. Curran, Dayenne G. van Leeuwen, Carlos Fernández de Larrea, Yunxin Chen, Mette Stæhr and Eric L. Smith and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Andrea V. Lopez

10 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea V. Lopez United States 8 503 229 204 151 123 10 586
Malgorzata Olszewska United States 11 360 0.7× 177 0.8× 311 1.5× 131 0.9× 198 1.6× 19 612
James Dongjoo Ham United States 6 643 1.3× 550 2.4× 210 1.0× 132 0.9× 96 0.8× 9 832
Brigitte Neuber Germany 16 529 1.1× 229 1.0× 260 1.3× 140 0.9× 169 1.4× 42 698
Chenggong Li China 12 399 0.8× 106 0.5× 247 1.2× 106 0.7× 121 1.0× 36 566
Stefanie Lesch Germany 8 686 1.4× 278 1.2× 284 1.4× 211 1.4× 188 1.5× 10 798
Elisabetta Cribioli Switzerland 9 428 0.9× 231 1.0× 178 0.9× 107 0.7× 162 1.3× 15 522
Mohamed-Reda Benmebarek Germany 9 594 1.2× 259 1.1× 213 1.0× 190 1.3× 148 1.2× 17 686
Diogo Gomes‐Silva United States 6 759 1.5× 274 1.2× 329 1.6× 180 1.2× 312 2.5× 9 857
Karen Dengel United States 8 547 1.1× 226 1.0× 245 1.2× 139 0.9× 121 1.0× 8 616
Simon Thomas United Kingdom 10 677 1.3× 201 0.9× 279 1.4× 266 1.8× 215 1.7× 28 773

Countries citing papers authored by Andrea V. Lopez

Since Specialization
Citations

This map shows the geographic impact of Andrea V. Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea V. Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea V. Lopez more than expected).

Fields of papers citing papers by Andrea V. Lopez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea V. Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea V. Lopez. The network helps show where Andrea V. Lopez may publish in the future.

Co-authorship network of co-authors of Andrea V. Lopez

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea V. Lopez. A scholar is included among the top collaborators of Andrea V. Lopez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea V. Lopez. Andrea V. Lopez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jaspers, Janneke E., et al.. (2023). IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models. Journal of Clinical Investigation. 133(9). 96 indexed citations
2.
Casado, José Antonio, Antonio Valeri, Rebeca Sánchez‐Domínguez, et al.. (2022). Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. Journal of Clinical Investigation. 132(15). 4 indexed citations
3.
Wijewarnasuriya, Dinali, et al.. (2020). Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells. Cancer Immunology Research. 8(6). 732–742. 24 indexed citations
4.
Drakes, Dylan J., Sarwish Rafiq, Terence J. Purdon, et al.. (2020). Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy. Cancer Immunology Research. 8(6). 743–755. 24 indexed citations
5.
Larrea, Carlos Fernández de, Mette Stæhr, Andrea V. Lopez, et al.. (2020). Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma. Blood Cancer Discovery. 1(2). 146–154. 147 indexed citations
6.
Li, Xinghuo, Anthony F. Daniyan, Andrea V. Lopez, Terence J. Purdon, & Renier J. Brentjens. (2020). Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response. Leukemia. 35(2). 506–521. 50 indexed citations
7.
Kuhn, Nicholas F., et al.. (2020). CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function. Nature Communications. 11(1). 6171–6171. 29 indexed citations
8.
Lopez, Andrea V., et al.. (2020). Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia. JAAD Case Reports. 6(12). 1303–1306. 5 indexed citations
9.
Larrea, Carlos Fernández de, Mette Stæhr, Andrea V. Lopez, et al.. (2019). Optimal Dual-Targeted CAR Construct Simultaneously Targeting Bcma and GPRC5D Prevents Bcma-Escape Driven Relapse in Multiple Myeloma. Blood. 134(Supplement_1). 136–136. 20 indexed citations
10.
Kuhn, Nicholas F., Terence J. Purdon, Dayenne G. van Leeuwen, et al.. (2019). CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response. Cancer Cell. 35(3). 473–488.e6. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malgorzata Olszewska Breakdown of academic impact, for papers by James Dongjoo Ham Breakdown of academic impact, for papers by Brigitte Neuber Breakdown of academic impact, for papers by Chenggong Li Breakdown of academic impact, for papers by Stefanie Lesch Breakdown of academic impact, for papers by Elisabetta Cribioli Breakdown of academic impact, for papers by Mohamed-Reda Benmebarek Breakdown of academic impact, for papers by Diogo Gomes‐Silva Breakdown of academic impact, for papers by Karen Dengel Breakdown of academic impact, for papers by Simon Thomas
Rankless by CCL
2026